Kingkey Intelligence Culture Holdings Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. For the period, the group anticipated that the net loss for the 2023 Interim Period would be widened to approximately HKD 10 million compared with approximately HKD 1.2 million in last corresponding period. The significant increase in net loss was largely due to (i) the decrease in turnover contributed from medical and health services business as a resulted of the end of COVID-19 pandemic; (ii) the increase in administrative expenses; and (iii) share of loss of the Group's associate, Aurora Medical Technology (HK) Corp.

Limited, during the 2023 Interim Period.